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Abstract
Background: Pelvic girdle pain (PGP) is a multifactorial condition, which can be mentally and physically
compromising both during and after pregnancy. However, long-term pregnancy-related PGP has been poorly
investigated. This longitudinal follow-up study uniquely aimed to describe prevalence and predictors of PGP and its
consequences on women’s health and function up to 11 years after pregnancy.
Methods/Design: A postal questionnaire was sent to 530 women who participated in 1 of 3 randomized
controlled studies for PGP in pregnancy. Women who reported experiencing lumbopelvic pain were offered a
clinical examination. Main outcome measure was the presence of long term PGP as assessed by an independent
examiner. Secondary outcomes were: working hours/week, function (the Disability Rating Index, and Oswestry
Disability Index), self-efficacy (the General Self-Efficacy Scale), HRQL (Euro-Qol 5D and EQ-Visual scale), anxiety and
depression, (Hospital anxiety and depression scale,) and pain-catastrophizing (Pain Catastrophizing Scale), in women
with PGP compared to women with no PGP.
Results: A total of 371/530 (70 %) women responded and 37/ 371 (10 %) were classified with long-term PGP.
Pregnancy-related predictors for long-term PGP were number of positive pain provocation tests (OR = 1.79), history of
low back pain (LBP) (OR = 2.28), positive symphysis pressure test (OR = 2.01), positive Faber (Patrick’s) test (OR = 2.22),
and positive modified Trendelenburg test (OR = 2.20). Women with PGP had significantly decreased ability to perform
daily activities (p < .001), lower self-efficacy (p = 0.046), decreased HRQL (p < .001), higher levels of anxiety and
depression (p < .001), were more prone to pain catastrophizing, and worked significantly fewer hours/week (p = 0.032)
compared to women with no PGP.
Conclusions: This unique long-term follow up of PGP highlights the importance of assessment of pain in the
lumbopelvic area early in pregnancy and postpartum in order to identify women with risk of long term pain. One of 10
women with PGP in pregnancy has severe consequences up to 11 years later. They could be identified by number of
positive pain provocation tests and experience of previous LBP. Access to evidence based treatments are important for
individual and socioeconomic reasons.
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Background
Pelvic girdle pain (PGP) is a multifactorial condition
with a partly unknown aetiology [1, 2] PGP can be men-
tally and physically compromising both during and after
pregnancy [2–12]. Previous research reports a preva-
lence of PGP from the postpartum stage to 3 years after
childbirth from 1 to 43 % [13–16], and 7 % at 6 years
[17]. Disability and pain intensity in pregnancy are asso-
ciated with sick leave due to pain in pregnancy and
persistent pain [16, 18, 19]. Some studies have focused
on prevalence, consequences, risk factors, prognostic
factors [2, 9, 13, 16–18, 20–35] and protecting factors
while others have evaluated treatment outcomes [36–
38]. However, the prevalence predictors and conse-
quences of long-term pregnancy-related PGP have been
poorly investigated.
Guidelines for the diagnosis of PGP state that this pain
is experienced between the posterior iliac crest and the
gluteal fold, particularly in the vicinity of the sacroiliac
joints (SIJ), separately or in conjunction with pain in the
symphysis, and that pain and functional disturbances in
relation to PGP must be reproducible by specific clinical
tests [5]. In most studies, however, no examination
during pregnancy was performed, and there is no study
with more than a 3-year follow-up postpartum that has
classified PGP by clinical examination [14]. Women with
a pelvic girdle syndrome (PGS), i.e. an anterior and pos-
terior pain location, have been found to have the worst
prognosis, and those with isolated anterior, i.e. symphy-
siolysial pain, the best prognosis [13].
Suggested pregnancy-related predictors for long-term
PGP include demographic variables, such as: age [2, 23,
27] and high Body Mass Index (BMI) [16], work-related
variables strenuous work [28] and sick leave [29],
delivery-related variables e.g. previous caesarean section
[21, 26, 30], and higher fetal weight [20], PGP-related
variables e.g. previous low back pain (LBP) [2, 31], hy-
permobility [16], severe pain [2, 16], decreased function
[31], ≥8 h sleep or rest/day [20], PGS [13, 32], difficulty
in performing the Active Straight Leg Raise test [33],
number of positive pain provocation tests [31, 34, 39]
and emotional distress [25].
Development from acute to chronic pain is complex,
and more research is needed to explore why some women
develop long-term PGP after delivery, which women are
at greater risk, and whether prevention is possible. To our
knowledge, this is the only longitudinal follow-up study
describing the prevalence, predictors and consequences of
PGP up to 11 years after pregnancy.
Methods
Data were obtained through one self-administered
questionnaire, sent and returned by mail. Two reminders
were sent. Presence of lumbopelvic pain (LPP) was
assessed by one question, recommended by a modified
Delphi study conducted with 28 experts in back pain
research from 12 countries [40]. According to the above
mentioned recommended question, women were asked
whether they had experienced LPP with or without radi-
ation into either or both legs during the past 4 weeks.
The pain should have been bad enough to limit usual
activities or cause changes in daily routines for more
than one day. The questionnaire included information
about the follow-up study and contact details for
additional information.
Outcome measures
The primary outcome measure and dependent variable
was the presence of long-term PGP.
Secondary outcomes were marital status, educational
level, physical activity, employment, working hours/
week, ability to take breaks at work, number of pregnan-
cies, parity, caesarean section and birth weight and sex
of last born baby, use of hormonal contraceptives, and
menopause. Function was measured on the Disability
Rating Index (DRI) [41] and the Oswestry Disability
Index (ODI) [42]. The DRI [41] measures ability in 12
activities, indicated on a100 mm visual analogue scale
(VAS) (where 0 = the ability to perform an activity with-
out difficulty, and 100 = no ability whatsoever to perform
the activity) [43]. An index is achieved by measuring the
distance in millimeter from 0 to the women’s markings
on the VAS. The mean of these measurements provides
the DRI expressed in percent of the highest possible
rating. Pain when ‘turning in bed’ (where 0 = no pain
and 1 = pain) was also queried, since this was performed
in the original RCTs [44–46]. Ten different items on
perceived disability were rated on the ODI: pain inten-
sity, personal care and lifting, walking, sitting, standing,
sleeping, sexual life, social life and travelling. The items
were scored from 0 to 5. The scores of all items were
added, giving a possible maximum score of 50. The total
score was then doubled and expressed as percentages
where 0 % represents no disability, 0–20 % no or
minimal disability, 20–40 % moderate disability, 40–
60 % severe disability, 60–80 % crippled and 80–100 %
bed bound. Health-related quality of life (HRQL) was
measured with the European quality of life measure (the
EuroQol- 5Dimensions (EQ-5D), and the EQ-Visual
analogue Scale (EQ-VAS) [47]. The EQ- 5D [47] assesses
five dimensions of HRQL: mobility, self-care, activities of
daily life, pain. Levels of anxiety and depression were
measured. For each dimension, the woman describes
three possible levels of problems (none, mild to moder-
ate and severe). This descriptive system contains 243
combinations or index values for state of health. The
total score range is from −0.43 to 1.0, in which -0.43 is
the lowest health state, and 1, the highest. For a normal
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population, the average value is 0.8-0.9 [48]. The EQ-5D
VAS is a vertical VAS (0–100 in which 0 is the lowest
conceivable health state, and 100 the optimal health
state) [47]. Levels of anxiety and depression was mea-
sured on the Hospital Anxiety and Depression Scale
(HADS) [49]. The HADS is a 14-item scale for detection
of anxiety and depression in people with physical health
problems. Seven items relate to anxiety (HADS-A) and 7
items to depression (HADS-D). Each item on the ques-
tionnaire is scored from 0-3, indicating that a person
can score between a total of 0 and 21 for either anxiety
or depression. A cut-off point of 8/21 for anxiety or de-
pression has been identified [50]. For anxiety this gave a
specificity of 0.78, and a sensitivity of 0.9. For depres-
sion, this gave a specificity of 0.79, and a sensitivity of
0.83 [50]. Self-efficacy was measured with the General
self-efficacy Scale (GES) [51]. The GES [51] is a 9-item
scale that measures self-efficacy, and the range is from
10-40 points, a sum score is usually calculated. Pain cat-
astrophizing was measured with the Pain Catastrophiz-
ing Scale (PCS). The PCS [52] was developed as a self-
report measurement tool that provided a valid index of
catastrophizing in clinical and non-clinical populations
[52]. The PCS is a 13-item self-report scale to measure
thoughts and feelings related to pain (e.g. “when I am in
pain, I worry all the time about whether the pain will
end”). In the PCS, each item is rated on a 5-point scale:
(in which 0 is not at all, and 4, constantly). A total score
is calculated (range 0-65 points). The three subscales of
magnification, rumination, and helplessness reveal differ-
ent dimensions of the same underlying content. Women
stating LPP were also asked questions about sleep, use
of analgesia, sick-leave due to LPP, and severity of LPP
in relation to work, and offered an examination.
Assessment
Women experiencing LPP in the questionnaire were
contacted by telephone. During the telephone interview
they could confirm the prevalence, location and severity
of symptoms, and were asked about exclusion criteria
i.e. on-going pregnancy and/or systemic disease. If they
fulfilled the criteria and agreed on an examination, they
were scheduled to one of two specially trained physio-
therapists. A standardised and reliable assessment [53]
was performed in order to classify the women’s LPP into
the categories PGP, PGP plus LBP, or only LBP. The
classification included a history of pain provocation in
different positions or activities of daily living, pelvic pain
provocations tests, and a standardised mechanical as-
sessment of the lumbar spine according to Mechanical
Diagnosis and Therapy [53]. This assessment also in-
cluded repeated end range flexion and extension move-
ments in standing position and/or in lying position. The
pelvic pain provocation tests used were: the posterior
pelvic pain provocation test (P4 test) [54], distraction
test, compression test, sacral thrust [53] and the MAT-
test [55]. The MAT-test: standing with one hip in abduc-
tion; perform an adduction simulating the movement to
pull a mat. The MAT-test was added as a replacement
for the symphysis pubis pressure test [55, 56]. The rea-
son for the decision to use the MAT test instead of the
symphysis pubic pressure test was both ethically and sci-
entifically based. The symphysis pubic pressure test pro-
vokes severe pain that does not subside directly, and the
test has been shown to be false positive in women with
no PGP [56]. The MAT test has been shown to have a
high percentage of agreement with palpation of the
pubic symphysis. [55]. In order to use the same classifi-
cation used in the original RCTs [44–46]. The Faber
(Patrick's) test and modified Trendelenburg test were
also performed [57]. A neurological examination was
performed if the women had a history of pain radiating
into the leg. Load transfer between trunk and pelvis
evaluated the active straight leg test (ASLR test) [58]. A
classification of PGP was defined according to European
guidelines [5]. All of the following criteria had to be
fulfilled:
 Pain experienced between the posterior iliac crest
and the gluteal fold, particularly in the vicinity of
the SIJ in conjunction with/or separately in the
symphysis.
 Reports of duration and weight-bearing-related pain
in the pelvic girdle.
 Diminished endurance in standing, walking and
sitting.
 Positive clinical diagnostic tests, which reproduced
pain in the pelvic girdle.
 No nerve root syndrome
 No reproducible pain and/or changed symptoms in
the lumbar spine by repeated end range movement.
A classification of LBP was defined as:
 Reported pain in the lumbar spine with or without
radiation to the leg.
 Reproducible pain and/or changed symptoms in the
lumbar spine by repeated end range motion [53].
A classification of combined PGP and LBP were de-
fined when both of the above criteria were fulfilled.
Since the focus of this follow up was to study long-term
PGP, women with PGP and women with PGP + LBP are
hereafter presented in the same group and named ‘PGP’.
Severity of PGP
Predictors of PGP were grouped and described in 5 clus-
ters e.g., demographic, work-related, pregnancy-related
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and PGP-related predictors. The demographic predictor
was age at randomisation in the RCT. Work-related pre-
dictors included severity of PGP in relation to work at
randomisation, ability to take breaks at work, and sick
leave due to PGP at randomisation. Pregnancy-related
predictors were age at menarche plus total number of
pregnancies and parity at the follow-up. PGP-related
predictors were: a history of LBP before randomisation,
function on the DRI [41], pain when turning in bed,
HRQL (EQ-5D and EQ-VAS) [47], pain intensity related
to motion in the morning and evening on a 0-100 mm
VAS [43], unpleasantness of PGP on a 0-100 mm VAS,
the P4 test [54], Faber (Patrick's) test, the symphysis
pubis pressure test, the modified Trendelenburg's test
[57], and the ASLR test [59] at randomisation. However,
EQ-5D, EQ-VAS and the ASLR test were not used in
Elden et al. 2005 [44].
The median, CI, quartiles, means and SD were calcu-
lated when appropriate. Continuous variables are pre-
sented with mean, Standard Deviation (SD) and 95 %
Confidence Interval or median, minimum and max-
imum, and categorical variables are presented with num-
ber and percentage. For comparison between groups
Fisher´s Exact test was used for dichotomous variables,
Mantel-Haenszel’s Chi Square Exact test for ordered
categorical variables, Chi Square test for non-ordered
categorical variables and the Mann-Whitney U-test were
used for continuous variables. In order to find independ-
ent predictors to occurrence of PGP, all significant
variables from the univariable step were entered into a
stepwise multivariable forward logistic regression. P < 0.10
was the prerequisite entry in the stepwise model. The re-
sults of the logistic regression analysis are presented as
Odds Ratio (OR) with a 95 % confidence interval for each
predictor and as the area under the ROC curve (AUC) for
the strongest predictor. All significance tests were two-
sided and conducted at the 5 % significance level. All stat-
istical analysis was performed with SAS System version 9,
SAS Institute, Cary, NC, USA.
Results
Of 536 women in one of the three original studies, only
530 questionnaires were sent out, since six women had
participated in two of the RCTs. A total of 371 (70 %)
responded to the questionnaire. However 11 women
were excluded due to systemic disease and 15 due to on-
going pregnancy. Thirty-seven/345 (10.7 %) women were
classified with PGP. The clinical classification showed
that 16 women suffered from PGP, and 21 women from
PGP plus LBP. Among the women with PGP; two
women had only an anterior pain location i.e. symphy-
siolysis; nine had a posterior pain location; and five had
both anterior and posterior pain compared to women
“with” no PGP at follow up. Figure 1 shows the progress
of participants throughout the study, and the results of
the examination at follow-up.
Table 1 shows the baseline characteristic of the study
population by PGP and no PGP. More women with per-
sistent PGP had previous LBP and the women had a
higher number of positive pain provocation tests com-
pared to women with no PGP at follow-up.
Table 2 shows the characteristics of the study population
at follow-up. Women with PGP worked significantly fewer
hours/week compared to women with no PGP at follow-
up. In addition, sleep was disturbed in 26/37 (70 %)
women, and 19/35 (54 %) women reported that their PGP
was affected by the menstrual cycle (data not shown).
Table 3 shows results of measurements of function
(DRI, ODI), HRQL (EQ-5D, EQ-VAS, anxiety and de-
pression (HADS), and pain catastrophizing (PCS) in
women with PGP and women with no PGP at follow-up.
Women classified with PGP had a significantly de-
creased ability to perform daily activities, lower self-
efficacy, and decreased HRQL compared to women
without PGP. Moreover, they had significantly higher
levels of anxiety, depression and pain catastrophizing
than women with no PGP. The time interval between
original randomisation and follow-up did not impact the
outcome measures assessed.
Figure 2 shows the result of the univariable logistic re-
gressions with variables measured in pregnancy from the
37 women with PGP compared to the results from the
290 women with no PGP. Earlier LBP (Odds Ratio, OR
= 2.28), a positive symphysis pressure test (OR = 2.01),
positive Faber (Patrick’s) test (OR = 2.22), a positive
modified Trendelenburg test (OR = 2.20), and a high
number of bilateral positive pain provocation tests (OR
= 1.79) were predictors for long-term PGP. In the step-
wise multivariable logistic regression the variable of a
high number of bilateral positive pain provocation tests
were entered into the model and resulted in an OR =
1.79 with a 95 % CI of 1.25-2.57 a P-value of 0.0015, and
an area under the ROC-Curve of 0.65 with a 95 % CI of
0.55-0.75. After that no other variable was entered in to
the model.
There was no association between characteristics reg-
istered at the follow-up such as: age at menarche, total
number of pregnancies, parity, caesarean section (yes/
no), birth weight (grams) or sex of last born baby and




Ten percent of women classified with PGP in pregnancy
had PGP with considerable consequences on health and
function in daily life up to a decade later. Pregnancy-
related predictors for long-term PGP were: a history of
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LBP before index pregnancy, a high number of positive
pain provocation tests, a positive symphysis pressure
test, and a modified Trendelenburg or Patrick’s test.
Some of the predictors were already known from shorter
follow-up studies such as a history of LBP before preg-
nancy [2, 9, 27, 31] and a high number of positive pain
provocation tests in pregnancy [31, 34], but Faber (Patri-
ck's) test, the modified Trendelenburg’s and the symphy-
sis pubic pressure tests as predictors are new findings.
However, the Faber (Patrick's) test, as a predictor must
be interpreted with caution since this is not a specific
test for PGP.
In contrast to other follow-up studies [9, 12, 31],
HRQL, decreased function, and high pain intensity were
not shown to be significant pregnancy-related predictors.
This may be explained by shorter follow-up periods in
those studies, and that women with long-term PGP may
have adjusted and confined their lives to decrease pain
exacerbation. Also, a recently published syndrome-
specific instrument may have been better for identifying
PGP-specific functional limitations than the DRI [60].
That work-related factors such as strenuous work [28]
and sick leave [29] were not confirmed as predictors
may be interpreted by changes in work-related circum-
stances during the long time elapsed, and that sick leave
is influenced by many factors, not only the severity of
PGP. [19] Moreover, our study did not confirm age as a
predictor for long-term PGP [23, 27]. However, age has
been suggested as a bimodal factor due to conflicting re-
sults [2]. Neither did our study confirm that higher fetal
weight [20] could predict long-term PGP. Nonetheless,
the mean weight of the fetuses in the aforementioned
study (3531 gram) was lower than the mean weight of
the fetuses in both the PGP group and the non-PGP
group in our study (3633, and 3692 grams, respectively).
Moreover, other studies have [21, 26, 30] described an
association between elective caesarean section and LBP
3 and 6 months after delivery, respectively. However,
their results must be interpreted with caution because of
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Fig. 1 Flow-chart of the study
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Table 1 Characteristics of women with PGP or PGP plus LBP and women with no PGP before inclusion in RCT in pregnancy
Variable PGP or PGP + LBP (n = 37) No PGP (n = 290) p-value
Treatment in RCT
Standard treatment 11 (29.7 %) 77 (26.6 %)
Standard treatment + Acupuncture 14 (37.8 %) 129 (44.5 %)
Standard treatment + Specific stabilising exercises 4 (10.8 %) 56 (19.3 %)
Standard treatment + Craniosacral therapy 8 (21.6 %) 28 (9.7 %) 0.11
Age, years 30.0 (23.0; 39.0) 31.0 (20.0; 43.0) 0.40
n = 37 n = 289
BMI before pregnancy 22.6 (19.7; 34.2) 23.2 (18.0; 38.4) 0.99
n = 23 n = 115
Age at menarche, years 13.0 (10.0; 15.0) 13.0 (9.0; 16.0) 0.63
n = 32 n = 248
Previous LBP 24 (64.9 %) 127 (44.7 %) 0.032
Women on sick-leave due to PGP 13 (35.1 %) 143 (50.0 %) 0.13
Severity of PGP
No complaints, PGP do not affect ability to work 1 (2.7 %) 5 (1.8 %)
Moderate complaints, PGP only affect ability to work sporadically 5 (13.5 %) 67 (23.8 %)
Not insignificant, cannot do some parts of my work 15 (40.5 %) 90 (32.0 %)
Severe, can almost not work 12 (32.4 %) 79 (28.1 %)
Severe, cannot work at all 4 (10.8 %) 40 (14.2 %) 0.80
Tests for assessment of PGP before inclusion in the RCT
Pain provocation tests
P4 test 37 (100.0 %) 283 (97.6 %) 0.86
Symphysis pressure test 22 (59.5 %) 121 (42.2 %) 0.070
Patrick Faber test 27 (73.0 %) 159 (54.8 %) 0.051
Modified Trendelenburg test 22 (59.5 %) 116 (40.0 %) 0.039
Number of bilateral positive pain provocation tests
0 0 (0.0 %) 3 (1.0 %)
1 6 (16.2 %) 58 (20.0 %)
2 6 (16.2 %) 107 (36.9 %)
3 10 (27.0 %) 81 (27.9 %)
4 15 (40.5 %) 41 (14.1 %) 0.0013
Functional test
ASLR test (sum of scores) 3.00 (0.00; 8.00) 3.00 (0.00; 10.00) 0.35
n = 23 n = 116
Subgroups of pelvic girdle pain
Solely symphysiolysis 0 (0.0 %) 5 (1.7 %) 1.00
One sided sacroiliac pain 3 (8.1 %) 37 (12.8 %) 0.61
One sided sacroiliac pain + symphyseal pain 6 (16.2 %) 39 (13.4 %) 0.80
Double sided sacroiliac pain 12 (32.4 %) 118 (40.7 %) 0.43
Pelvic girdle syndrome 16 (43.2 %) 91 (31.4 %) 0.21
Pain related to motion
In the morning, VAS 31.0 (8.0; 92.0) 26.5 (0.0; 96.0 0.089
In the evening, VAS 62.0 (5.0; 93.0) 62.8 (6.0; 100.0) 0.30
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for caesarean delivery or vaginal delivery were not
explored. Also, none of these studies used a medical
examination for classification of PGP [20, 21, 26].
It is not surprising that long-term PGP, in common
with many other chronic pain conditions, was associated
with decreased HRQL, function, and psychosocial fac-
tors i.e. disturbed sleep, anxiety, depression, self-efficacy
and pain catastrophizing [61, 62]. Anxiety and depres-
sion may act as facilitators of pain nociception, making
the pain worse, and pain, in turn, may act as facilitators
of anxiety and depression [63]. Sleep disturbance is also
an important factor of chronic pain to identify and ad-
dress [20]. However, as these factors were not measured
in pregnancy no conclusions can be drawn regarding
their predictive value and role in the development from
acute to chronic PGP.
The results presented are also in line with earlier pub-
lications of persistent LBP and PGP in a shorter
perspective. However, the prevalence of PGP was higher
(10 %) in our study than in a 6-year postpartum follow-
up study (7 %) [17]. The higher rate in our study can be
explained by differences in the study populations, i.e. the
women in our study may have had more severe PGP in
pregnancy since they sought treatment, and that women
participating in RCT 2-3 [45, 46] fulfilled the inclusion
criteria of evening pain of at least 50/100. Two of the
women had only symphysiolysis. Although this is a small
number of women, there is a need to reconsider if
women with isolated symphysiolysis recover completely
as previously suggested [13].
Strengths and limitations
There is a relative paucity of literature in this area. The
topic is very important clinically, as pregnancy-
associated musculoskeletal pain is highly prevalent and
associated with significant morbidity that has a major
Table 1 Characteristics of women with PGP or PGP plus LBP and women with no PGP before inclusion in RCT in pregnancy
(Continued)
n = 37 n = 288
Unpleasantness of PGP, VAS 63.0 (20.0; 100.0) 73.0 (0.0; 100.0) 0.068
n = 30 n = 200
DRI 50.0 (23.0; 100.0) 59.0 (11.0; 100.0) 0.11
n = 37 n = 279
EQ-VAS 40.0 (25.0; 100.0) 50.0 (20.0; 99.0) 0.37
n = 23 n = 113
EQ-5D score 0.620 (-0.016; 0.760) 0.620 (-0.074; 0.796) 0.23
n = 23 n = 112
Education level
Primary school 0 (0.0 %) 5 (2.0 %)
Secondary school 11 (33.3 %) 64 (25.3 %)
College 5 (15.2 %) 21 (8.3 %)
University degree 17 (51.5 %) 163 (64.4 %) 0.37
No or rare ability to take rest breaks at work 4 (13.8 %) 68 (29.8 %) 0.18
Physical activity ≥30 minutes during leisure before pregnancy, days/week
0 3 (9.1 %) 8 (3.2 %)
1 1 (3.0 %) 20 (7.9 %)
2 3 (9.1 %) 43 (17.1 %)
3 7 (21.2 %) 57 (22.6 %)
4 5 (15.2 %) 31 (12.3 %)
5 3 (9.1 %) 37 (14.7 %)
6 2 (6.1 %) 13 (5.2 %)
7 9 (27.3 %) 43 (17.1 %) 0.35
For comparison between groups Fisher’s Exact test was used for ichotomous variables and the Mantel-Haenszel Chi Square Exact test was used for ordered
categorical variables and the Mantel-Haenszel Chi Square test was used for ordered categorical variables and Chi Square Exact test was used for non-ordered
categorical variables and Chi Square test was used for non-ordered categorical variables and the Mann-Whitney U-test was used for continuous variables
PGP pelvic girdle pain, LBP Low back pain, RCT Randomized controlled trial, BMI Body mass index, P4-test Posterior pelvic pain provocation test, ASLR-test Active
straight leg test, VAS visual analoge scale. DRI Disability Rating Index; EQ-5D European Quality of Life measure – five dimensions; EQ-VAS European Quality of Life
measure – visual analog scale. For categorical variables n (%) is presented. For continuous variables Mean (SD) / Median (Min; Max) / n = is presented
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socioeconomic impact on physical medicine as well as
obstetric services.
The main strength of this work lies in that it is based
on the follow-up of relatively robust randomised con-
trolled trials, plus a relatively good response rate (71 %)
from the original participants despite the time interval
of up to 11 years. It is noteworthy that 26 of 37 respon-
dents in the PGP group (70 %) and 213 of 290 respon-
dents in the no PGP group (73 %) were in the active
arms of the original trials, suggesting that fewer women
randomised to the control arms (standard treatment
only) completed the questionnaire. However, a majority
of the women reporting LPP responded after the first
questionnaire. None reporting LPP responded after re-
minder 2, which confirms the assumption that these
women did not respond to the questionnaire because of
the resolution of their LPP rather than neglect or other
reasons. Prompt responses may also reflect the fact that
many of these women receive insufficient care from
healthcare provider’s barriers they encounter in seeking
help [4, 64]. This can also be due to postpartum PGP be-
ing a neglected area of research. This is unacceptable
both for the individual experiencing PGP and for the so-
cietal consequences of long-term pregnancy-related
PGP. There was no evidence of bias caused by partici-
pant dropout on the prognostic factors or outcome;
Table 2 Characteristics of women with PGP or PGP plus LBP and women with no PGP at follow-up
Variable PGP or PGP + LBP (n = 37) No PGP (n = 290) p-value
Age, years 37.7 (4.9) 39.4 (5.7) 0.059
38.0 (29.0; 49.0) 40.0 (24.0; 54.0)
n = 37 n = 290
Time from randomisation to follow-up (years) 7.35 (4.02) 8.41 (3.80) 0.27
5.00 (2.00; 12.00) 11.00 (1.00; 13.00)
Working hours/week 35.7 (7.6) 37.1 (6.5) 0.032
38.0 (19.0; 60.0) 40.0 (1.0; 49.0)
n = 29 n = 221
Marital status
Single 3 (8.6 %) 24 (9.5 %)
Married/cohabitating 32 (91.4 %) 229 (90.5 %) 1.00
Number of pregnancies
1 4 (12.1 %) 18 (7.2 %)
2 8 (24.2 %) 89 (35.6 %)
3 15 (45.5 %) 69 (27.6 %)
4 6 (18.2 %) 73 (29.2 %)
5 0 (0.0 %) 1 (0.4 %) 0.56
Parity
1 5 (14.7 %) 30 (12.0 %)
2 20 (58.8 %) 139 (55.4 %)
3 8 (23.5 %) 75 (29.9 %)
4 1 (2.9 %) 6 (2.4 %)
5 0 (0.0 %) 1 (0.4 %) 0.52
Caesarean section 4 (14.3 %) 48 (19.0 %) 0.76
Birthweight last born baby, grams 3633 (492) 3692 (490) 0.43
3548 (2995; 4615) 3700 (2129; 5000)
n = 30 n = 274
Sex of last born baby, boy 15 (50 %) 140 (51 %) 0.925
n = 30 n = 275
For comparison between groups Fisher’s Exact test was used for dichotomous variables and the Mantel-Haenszel Chi Square Exact test was usedfor ordered
categorical variables and the Mantel-Haenszel Chi Square test was used for ordered categorical variables and Chi Square Exact test was used for non-ordered
categorical variables and Chi Square test was used for non-ordered categorical variables and the Mann-Whitney
U-test was used for continuous variables
PGP pelvic girdle pain, LBP Low back pain, For categorical variables n (%) is presented. For continuous variables Mean (SD) / Median (Min; Max) / n = is presented
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Table 3 Function (ODI), health related quality of life (EQ-5D, EQ-VAS), Anxiety and depression (HADS) and pain catastrophisation
(PCS) in women PGP or PGP plus LBP and women with no PGP at follow-up
Variable PGP or PGP + LBP (n = 37) No pain (n = 290) p-value
ODI 22.0 (6; 42) 4.00 (0; 58) <.001
n = 31 n = 243
EQ-5D 0.725 (0.414; 1) 0.848 (0.222; 1) <.001
n = 25 n = 234
EQ -VAS 76.5 (50; 100) 86.0 (0; 100) <.001
n = 30 n = 230
HADS-A, sum of scores 66 (0; 14) 3 (0; 22) <.001
n = 32 n = 241
HADS-A > 8 10 (31.3 %) 24 (10.0 %) 0.0044
HADS-D, sum of scores 2.50 (0; 12) 1.00 (0; 12) <.001
n = 32 n = 241
HADS-D, >8 2 (6.3 %) 4 (1.7 %) 0.30
PCS score 15.5 (0; 35) 6 (0; 52) <.001
n = 32 n = 237
PCS magnification 3.50 (0; 8) 1 (0; 12) <.001
n = 32 n = 241
PCS helplessness 6 (0; 17) 2 (0; 24) <.001
n = 32 n = 241
PCS rumination 5.50 (0; 11) 2 (0; 16) 0.0036
n = 32 n = 241
GSE (half scale) 33.0 (24.0; 40.0) 35.0 (10.0; 40.0) 0.046
n = 32 n = 239
DRI index 30.8 (2.8; 78.6) 4.62 (0; 55.85) <.001
n = 32 n = 243
DRI, Dressing 4 (0; 100) 1 (0; 26) <.001
n = 33 n = 241
DRI, Outdoor walks 11 (0; 90) 1.50 (0; 71) <.001
n = 33 n = 242
DRI, Climbing stairs 12 (0; 100) 2 (0; 77) <.001
n = 33 n = 243
DRI, Sitting for a longer time 30 (0; 80) 3 (0; 90) <.001
n = 33 n = 243
DRI, Get up from chair 13 (0; 100) 2 (0; 77) <.001
n = 33 n = 243
DRI, Standing bent 39 (0; 100) 3 (0; 94) <.001
n = 33 n = 243
DRI, Carrying a bag 22 (0; 97) 2 (0; 69) <.001
n = 33 n = 242
DRI, Running 38 (1; 100) 3 (0; 100) <.001
n = 33 n = 243
DRI, Light work 17 (0; 90) 2 (0; 79) <.001
n = 33 n = 243
DRI, Turn in bed 49 (2; 100) 3 (0; 98) <.001
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therefore, our findings are unlikely to be substantially
influenced by loss at follow-up.
There is a potential for greater confounding in the
group followed up at 11 years (the majority). These
women are ultimately likely to be older and more likely
to have had intercurrent pregnancies. However, there
was no statistical significant difference in the time
interval from randomisation to follow-up between
women with PGP and women without PGP.
The reason for using both the ODI and the DRI for
function was to be able to compare function measured
in pregnancy with function measured at follow-up. The
DRI was used in all the RCTs [44–46] but the ODI was
added in Elden et al. 2008 [45] and Elden et al. 2013
Table 3 Function (ODI), health related quality of life (EQ-5D, EQ-VAS), Anxiety and depression (HADS) and pain catastrophisation
(PCS) in women PGP or PGP plus LBP and women with no PGP at follow-up (Continued)
n = 33 n = 242
DRI, Heavy work 47 (0; 98.) 4 (0; 86) <.001
n = 33 n = 242
DRI, Lifting heavy 26 (2; 100) 3 (0; 75) <.001
n = 33 n = 243
DRI, Sports 17 (0; 100) 2 (0; 65) <.001
n = 33 n = 243
For comparison between groups Fisher’s Exact test was used for dichotomous variables and the Mann-Whitney U-test was used for continuous variables
PGP Pelvic girdle pain, LBP Low back pain, ODI Oswestry disability index, EQ-5D EuroQol-5 dimensions, EQ-VAS EuroQol-visual analogue scale, HADS-A Hospitality
anxiety depression score-anxiety, HADS-D Hospitality anxiety depression score-depression, PCS Pain catastrophisation scale, GES General self-efficacy scale. For
categorical variables n (%) is presented. For continuous variables Median (Min; Max) / n = is presented
Fig. 2 Association between baseline characteristics in pregnancy and the occurrence of PGP 2, 6 and 11 years after pregnancy. Result of the
univariable logistic regressions with variables measured in pregnancy
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[46] because some activities in the DRI e.g. running, lift-
ing heavy objects and participating in sports was found
inappropriate for women with PGP. The topics e.g. abil-
ity to care for oneself, ability to walk, ability to sit, sexual
function, ability to stand, social life, sleep quality, and
ability to travel in the ODI complements the DRI. The
topics reflect both decreased body functions, activities in
daily life and symptoms (pain), which are included in the
European Guidelines of diagnosis and treatment for PGP
[5] and reported in both quantitative [65] and qualitative
studies describing women’s reported difficulties of life by
women with PGP [8, 66–68] and their partners [69].
Other major strengths of this study are the relatively
large sample of women classified with PGP in pregnancy
[5] and baseline registration of pain and function before
inclusion in the RCTs. In addition the examination of
women with self-reported LPP was performed by skilled
physiotherapists using the same classification at follow-
up as in pregnancy, and the wide range of predictors
measured by validated instruments. Another strength
was that false positive pain provocation tests at follow-
up were minimized by the identification of lumbar pain
and the centralization phenomenon [70]. Furthermore,
the use of pain provocation tests minimized false nega-
tive cases [7].
Other strengths are that many of the instruments used in
this study have shown good internal consistency, test-retest
reliability, and construct validity when used with a sample
of participants with PGP postpartum [12, 17, 37, 71].
A weakness of our study was that the sample size (in
the women with PGP, n = 37) is not of sufficient number
to rule out a type II error for the small difference in the
primary and secondary outcome variables measured.
Moreover, BMI, breastfeeding and emotional distress
shown to influence the prognosis of PGP, were not in-
cluded [16, 24, 25, 35]. It may also be the case that pre-
dictors of PGP outcome are not fixed at specific time
points (i.e. baseline registration before inclusion in an
RCT) but are more fluid in nature and change, and
evolve during different periods of the women’s experi-
ences of PGP. Future studies with more frequent follow-
ups will better identify such patterns. In addition, the
study design could not control for other potential co-
morbid health conditions that may be accounting for an
individual's PGP. Although care was taken to exclude
any patients with current systemic disease (n = 11), the
possibility of other conditions being present at some
stage in the intervening years remains. Although parity
did not differ significantly between participants with
PGP versus those without PGP at follow-up, it remains
unclear whether or not any of these intervening preg-
nancies were complicated by musculoskeletal pain con-
ditions and whether there may have been a differential
effect between the women with or without PGP. We
have earlier shown that 99 % of women in the RCT per-
formed 11 years ago [72] reported resolution of their
pain by 12 weeks. Therefore pain reported 11 years later
in these women may be new-onset (i.e. have nothing to
do with the index pregnancy), or may indicate recur-
rence, i.e. is unlikely to reflect persistent pain. However,
the low prevalence shown 12 weeks after pregnancy [72]
might have reflected that the women had not yet re-
sumed with their daily activities. To definitively associate
the presence of PGP 11 years later with the index preg-
nancy without careful review of relevant events in be-
tween would potentially be misleading. Thus, the
generalizability (external validity) of the study results
may be limited to this population of women.
Interpretation
PGP is closely related to pregnancy, and most commonly
debuts in pregnancy. Thus, the debut of PGP is easy to
identify and screen. Based on the results of our study we
suggest that the classification of pregnant women with
self-reported LPP include an examination of both the
lumbar spine and the pelvic girdle, and that the P4 test
is used to identify women with posterior pelvic pain, and
the MAT-test for anterior pelvic pain, as these tests are
reliable and valid for posterior and anterior PGP [5, 7,
55]. In additon, more pelvic pain provocation tests can
be used to identify women with severe PGP, which in
turn will indicate that these women run a higher risk of
long-term PGP. The women should thereafter be offered
structured and individualised treatment depending on
the classification of their condition. Promising interven-
tions for PGP during pregnancy are acupuncture, a
semi-elastic belt, and specific stabilizing exercises [1, 44,
73]. Since it has been shown that improvement from
persistent PGP level off around 6 months postpartum
[74], It is of great importance that these women are
followed up. Women that are not symptom free by that
time most probably need individualised treatment de-
pending on the classification of their condition in order
to prevent long term pain [75, 76].
Conclusions
In conclusion, this unique long-term longitudinal study
highlights the importance of assessment and classifica-
tion of LPP in pregnancy and at postpartum follow-up
for the prediction of long-term PGP. One of ten women
classified with PGP during pregnancy have PGP with
severe consequences not only on women’s everyday life
but also on their family life and economy up to 11 years
later. Previous LBP and a high number of positive pain
provocation tests are pregnancy-related predictors last-
ing more than a decade. The severity of PGP in preg-
nancy thus seems important to identify early, which is
possible in most countries since these women are in
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frequent contact with the health care system. More
attention should be paid to pregnant women with a his-
tory of LBP and many positive pain provocation tests
and women with remaining PGP at follow-up postpar-
tum. Focus should be to minimize the symptoms and
consequences of PGP for the women. Further research
of this major health problem is needed.
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